Quarterly report · Q2
3401.TEDINET S100PIR6
Period2022-04-01 → 2022-09-30
Filed2022-11-14
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 49
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥510.5bn | 2022-04-01 → 2022-09-30 | Cons. | Net sales |
| Revenue | ¥926.1bn | 2021-04-01 → 2022-03-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥453.4bn | 2021-04-01 → 2021-09-30 | Cons. | Net sales |
| Operating income | ¥14.2bn | 2022-04-01 → 2022-09-30 | Cons. | Operating income |
| Operating income | ¥31.5bn | 2021-04-01 → 2021-09-30 | Cons. | Operating income |
| Ordinary income | ¥20.0bn | 2022-04-01 → 2022-09-30 | Cons. | Ordinary income |
| Ordinary income | ¥49.7bn | 2021-04-01 → 2022-03-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥32.6bn | 2021-04-01 → 2021-09-30 | Cons. | Ordinary income |
| Profit before tax | ¥19.8bn | 2022-04-01 → 2022-09-30 | Cons. | Income before income taxes |
| Profit before tax | ¥34.1bn | 2021-04-01 → 2021-09-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥7.6bn | 2022-04-01 → 2022-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥23.2bn | 2021-04-01 → 2022-03-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥21.6bn | 2021-04-01 → 2021-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥8.7bn | 2022-04-01 → 2022-09-30 | Cons. | Profit loss |
| Net income | ¥22.9bn | 2021-04-01 → 2021-09-30 | Cons. | Profit loss |
| Total assets | ¥1.31T | at 2022-09-30 | Cons. | Assets |
| Total assets | ¥1.21T | at 2022-03-31 | Cons. | Assets |
| Total assets | ¥1.17T | at 2021-09-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥822.2bn | at 2022-09-30 | Cons. | Liabilities |
| Total liabilities | ¥742.8bn | at 2022-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥482.9bn | at 2022-09-30 | Cons. | Net assets |
| Net assets / equity | ¥464.8bn | at 2022-03-31 | Cons. | Net assets |
| Net assets / equity | ¥450.6bn | at 2021-09-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥159.1bn | at 2022-09-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥134.5bn | at 2022-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥155.3bn | at 2022-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥130.7bn | at 2022-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥131.8bn | at 2021-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥166.5bn | at 2021-03-31d | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥32.1bn | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥89.7bn | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥33.9bn | 2021-04-01 → 2021-09-30 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥29.8bn | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥198.4bn | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥163.6bn | 2021-04-01 → 2021-09-30 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | ¥18.3bn | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥71.1bn | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥94.4bn | 2021-04-01 → 2021-09-30 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥39.41 | 2022-04-01 → 2022-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥1.59 | 2022-07-01 → 2022-09-30d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥120.58 | 2021-04-01 → 2022-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥112.34 | 2021-04-01 → 2021-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥61.29 | 2021-07-01 → 2021-09-30d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥39.34 | 2022-04-01 → 2022-09-30 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥115.72 | 2021-04-01 → 2022-03-31 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥106.08 | 2021-04-01 → 2021-09-30 | Cons. | Diluted earnings per share (5-year summary) |
| Equity ratio | 35.1% | at 2022-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 36.4% | at 2022-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 36.5% | at 2021-09-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 40
| Segment | Item | Period | Value |
|---|---|---|---|
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2022-04-01 → 2022-09-30 | ¥15.7bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2022-04-01 → 2022-09-30 | ¥13.5bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue intersegment | 2022-04-01 → 2022-09-30 | ¥2.2bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2022-04-01 → 2022-09-30 | −¥1.9bn |
| jpcrp040300-q2r_E00872-000Healthcarereportable segment | revenue | 2022-04-01 → 2022-09-30 | ¥78.7bn |
| jpcrp040300-q2r_E00872-000Healthcarereportable segment | revenue external | 2022-04-01 → 2022-09-30 | ¥78.7bn |
| jpcrp040300-q2r_E00872-000Healthcarereportable segment | revenue intersegment | 2022-04-01 → 2022-09-30 | ¥2m |
| jpcrp040300-q2r_E00872-000Healthcarereportable segment | segment profit | 2022-04-01 → 2022-09-30 | ¥14.7bn |
| jpcrp040300-q2r_E00872-000Materialreportable segment | revenue | 2022-04-01 → 2022-09-30 | ¥238.0bn |
| jpcrp040300-q2r_E00872-000Materialreportable segment | revenue external | 2022-04-01 → 2022-09-30 | ¥232.6bn |
| jpcrp040300-q2r_E00872-000Materialreportable segment | revenue intersegment | 2022-04-01 → 2022-09-30 | ¥5.5bn |
| jpcrp040300-q2r_E00872-000Materialreportable segment | segment profit | 2022-04-01 → 2022-09-30 | −¥4.5bn |
| —segment total | revenue | 2022-04-01 → 2022-09-30 | ¥506.7bn |
| —segment total | revenue external | 2022-04-01 → 2022-09-30 | ¥497.0bn |
| —segment total | revenue intersegment | 2022-04-01 → 2022-09-30 | ¥9.8bn |
| —segment total | segment profit | 2022-04-01 → 2022-09-30 | ¥19.0bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2022-04-01 → 2022-09-30 | ¥522.4bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2022-04-01 → 2022-09-30 | ¥510.5bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2022-04-01 → 2022-09-30 | ¥11.9bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2022-04-01 → 2022-09-30 | ¥17.0bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2021-04-01 → 2021-09-30 | ¥16.7bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2021-04-01 → 2021-09-30 | ¥14.8bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue intersegment | 2021-04-01 → 2021-09-30 | ¥1.9bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2021-04-01 → 2021-09-30 | −¥1.2bn |
| jpcrp040300-q2r_E00872-000Healthcarereportable segment | revenue | 2021-04-01 → 2021-09-30 | ¥87.0bn |
| jpcrp040300-q2r_E00872-000Healthcarereportable segment | revenue external | 2021-04-01 → 2021-09-30 | ¥86.9bn |
| jpcrp040300-q2r_E00872-000Healthcarereportable segment | revenue intersegment | 2021-04-01 → 2021-09-30 | ¥14m |
| jpcrp040300-q2r_E00872-000Healthcarereportable segment | segment profit | 2021-04-01 → 2021-09-30 | ¥24.2bn |
| jpcrp040300-q2r_E00872-000Materialreportable segment | revenue | 2021-04-01 → 2021-09-30 | ¥197.6bn |
| jpcrp040300-q2r_E00872-000Materialreportable segment | revenue external | 2021-04-01 → 2021-09-30 | ¥190.8bn |
| jpcrp040300-q2r_E00872-000Materialreportable segment | revenue intersegment | 2021-04-01 → 2021-09-30 | ¥6.8bn |
| jpcrp040300-q2r_E00872-000Materialreportable segment | segment profit | 2021-04-01 → 2021-09-30 | ¥3.3bn |
| —segment total | revenue | 2021-04-01 → 2021-09-30 | ¥450.1bn |
| —segment total | revenue external | 2021-04-01 → 2021-09-30 | ¥438.6bn |
| —segment total | revenue intersegment | 2021-04-01 → 2021-09-30 | ¥11.5bn |
| —segment total | segment profit | 2021-04-01 → 2021-09-30 | ¥35.8bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2021-04-01 → 2021-09-30 | ¥466.8bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2021-04-01 → 2021-09-30 | ¥453.4bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2021-04-01 → 2021-09-30 | ¥13.4bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2021-04-01 → 2021-09-30 | ¥34.7bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 564
| Item | Context | Value | Unit |
|---|---|---|---|
| Dividends income noi | CurrentYTDDuration | 771000000 | JPY |
| Equity in earnings of affiliates noi | Prior1YTDDuration | 2936000000 | JPY |
| Equity in earnings of affiliates noi | CurrentYTDDuration | 2555000000 | JPY |
| Gain on valuation of derivatives noi | Prior1YTDDuration | 796000000 | JPY |
| Gain on valuation of derivatives noi | CurrentYTDDuration | 11414000000 | JPY |
| Gain on investments in partnership noi | Prior1YTDDuration | － | JPY |
| Gain on investments in partnership noi | CurrentYTDDuration | 631000000 | JPY |
| Miscellaneous income noi | Prior1YTDDuration | 487000000 | JPY |
| Miscellaneous income noi | CurrentYTDDuration | 375000000 | JPY |
| Non operating income | Prior1YTDDuration | 5080000000 | JPY |
| Non operating income | CurrentYTDDuration | 16200000000 | JPY |
| Interest expenses noe | Prior1YTDDuration | 1517000000 | JPY |
| Interest expenses noe | CurrentYTDDuration | 2736000000 | JPY |
| Foreign exchange losses noe | Prior1YTDDuration | 391000000 | JPY |
| Foreign exchange losses noe | CurrentYTDDuration | 6642000000 | JPY |
| Loss on valuation of derivatives noe | Prior1YTDDuration | 247000000 | JPY |
| Loss on valuation of derivatives noe | CurrentYTDDuration | 457000000 | JPY |
| Loss on investments in partnership noe | Prior1YTDDuration | 444000000 | JPY |
| Loss on investments in partnership noe | CurrentYTDDuration | － | JPY |
| Miscellaneous loss noe | Prior1YTDDuration | 1322000000 | JPY |
| Miscellaneous loss noe | CurrentYTDDuration | 610000000 | JPY |
| Non operating expenses | Prior1YTDDuration | 3921000000 | JPY |
| Non operating expenses | CurrentYTDDuration | 10445000000 | JPY |
| Ordinary income | Prior1YTDDuration | 32621000000 | JPY |
| Ordinary income | CurrentYTDDuration | 19986000000 | JPY |
| Gain on sales of noncurrent assets ei | Prior1YTDDuration | 47000000 | JPY |
| Gain on sales of noncurrent assets ei | CurrentYTDDuration | 14000000 | JPY |
| Gain on sales of investment securities ei | Prior1YTDDuration | 3975000000 | JPY |
| Gain on sales of investment securities ei | CurrentYTDDuration | 1249000000 | JPY |
| Other ei | Prior1YTDDuration | 165000000 | JPY |
| Other ei | CurrentYTDDuration | 0 | JPY |
| Extraordinary income | Prior1YTDDuration | 4188000000 | JPY |
| Extraordinary income | CurrentYTDDuration | 1263000000 | JPY |
| Loss on sales and retirement of noncurrent assets el | Prior1YTDDuration | 910000000 | JPY |
| Loss on sales and retirement of noncurrent assets el | CurrentYTDDuration | 650000000 | JPY |
| Loss on valuation of investment securities el | Prior1YTDDuration | － | JPY |
| Loss on valuation of investment securities el | CurrentYTDDuration | 282000000 | JPY |
| Impairment loss el | Prior1YTDDuration | 1649000000 | JPY |
| Impairment loss el | CurrentYTDDuration | 140000000 | JPY |
| Business structure improvement expenses el | Prior1YTDDuration | 106000000 | JPY |
| Business structure improvement expenses el | CurrentYTDDuration | 24000000 | JPY |
| Loss related to covid19 el | Prior1YTDDuration | － | JPY |
| Loss related to covid19 el | CurrentYTDDuration | 319000000 | JPY |
| Other el | Prior1YTDDuration | 77000000 | JPY |
| Other el | CurrentYTDDuration | 72000000 | JPY |
| Extraordinary loss | Prior1YTDDuration | 2741000000 | JPY |
| Extraordinary loss | CurrentYTDDuration | 1487000000 | JPY |
| Income before income taxes | Prior1YTDDuration | 34067000000 | JPY |
| Income before income taxes | CurrentYTDDuration | 19762000000 | JPY |
| Income taxes | Prior1YTDDuration | 11178000000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |